Page last updated: 2024-08-17

prednisone and fludarabine

prednisone has been researched along with fludarabine in 129 studies

Research

Studies (129)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	34 (26.36)	18.2507
2000's	53 (41.09)	29.6817
2010's	36 (27.91)	24.3611
2020's	6 (4.65)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Burckhardt, G; Flörl, S; Hagos, Y; Kühne, A; Marada, VV	1
Anaissie, E; Elting, L; Kantarjian, H; Keating, M; Kontoyiannis, DP; Robertson, LE	1
Butler, JJ; Hirsch-Ginsberg, C; Huh, YO; Kantarjian, H; Keating, MJ; Pugh, WC; Robertson, LE; Stass, S	1
Phyliky, RL; Tefferi, A	1
Beran, M; Childs, C; Huh, Y; Kantarjian, HM; Keating, MJ; Koller, C; O'Brien, S; Schachner, J	1
Bendandi, M; Cantagalli, F; Macchi, S; Mancino, A; Simoncelli, F; Stefanati, V; Tura, S; Visani, G; Zaccaria, A; Zinzani, PL	1
Bosanquet, AG; Catovsky, D; Crotty, GM; McCann, SR; Mills, MJ	1
Bendandi, M; Tura, S; Zinzani, PL	1
Lundberg, JH; Tefferi, A; Weitz, JJ; Witzig, TE	1
Girmenia, C; Mauro, FR; Rahimi, S	1
Bapat, A; Goldberg, J; Goldman, N; Gordon, R; Gryn, J	1
Cleveland, KO; Gelfand, MS	1
Beran, M; Estey, E; Kantarjian, H; Keating, M; Koller, C; Lerner, S; O'Brien, S; Robertson, LE; Smith, T	1
Binet, JL	1
Emmerich, B; Hiddemann, W; Johnson, S; Juliusson, G; Löffler, H; Osby, E; Smith, AG; Wyld, PJ	1
Koeppen, H; Larson, RA; Olopade, OI; Ong, ST	1
Rai, KR	1
Aziz, M; Levin, M; Opitz, L	1
Brisou, P; de Jaureguiberry, JP; Gisserot, O; Hequet, O; Jaubert, D; Muzellec, Y	1
Bendandi, M; Gherlinzoni, F; Magagnoli, M; Merla, E; Tura, S; Zinzani, PL	1
Antich Rojas, J; Balaguer, H; Cladera, A	1
Chapman, R; Grigg, A; Szer, J	1
Catovsky, D; Killick, S; Matutes, E; Sternberg, AJ; Wotherspoon, AC	1
Anaissie, EJ; Kantarjian, H; Keating, MJ; Kontoyiannis, DP; Lerner, S; O'Brien, S; Robertson, L	1
Cawley, M; Kaplan, B; Narasihman, P; Taha, HM; Venkatesh, L	1
Azaceta, G; Gutierrez, M; Palomera, L; Soria, J; Varo, MJ	1
Adams, EM; Bartlett, ML; Fleisher, T; Hicks, JE; McGarvey, C; Plotz, PH; Pucino, F; Sonies, BC; Thornton, B; Villalba, ML; Yarboro, C	1
Berrebi, A; Klepfish, A; Shimoni, A; Shtalrid, M; Shvidel, L; Sigler, E	1
Kalaycio, M; Sen, K	1
del Potro Gómez, E; Morales Sanz, D	1
Hieke, K; Howard, P; Kerrigan, M; McIntyre, AM; Smartt, PF; Sweetenham, J; Townshend, S	1
Austin, HA; Balow, JE; Boumpas, DT; Fleisher, TA; Kim, Y; Piscitelli, S; Pucino, F; Tassiulas, IO; Vaughan, E	1
Belanger, C; Bouabdallah, R; Brice, P; Brousse, N; Coiffier, B; Haioun, C; Janvier, M; Neidhardt-Bérard, EM; Péaud, PY; Pico, JL; Solal-Celigny, P; Tilly, H	1
Calvo Villas, J; Ramírez Sánchez, M; Sicilia Guillén, F	1
Bambara, LM; Biasi, D; Caramaschi, P; Carletto, A	1
Byrd, JC; Flinn, IW; Grever, MR; Lehman, T; Lucas, D; Sausville, E; Shinn, C; Willis, CR	1
Cazin, B; Chevret, S; Delabarre, F; Leporrier, M; Levy, V; Porcher, R	1
Blume, KG; Chauncey, T; Feinstein, L; Flowers, C; Georges, G; Kiem, HP; Little, MT; Maloney, D; Maris, M; McSweeney, PA; Nash, RA; Niederwieser, D; Radich, J; Sandmaier, B; Shizuru, J; Storb, R; Woolfrey, A; Zaucha, JM	1
Cazin, B; Chevret, S; Fermand, JP; Guibon, O; Harousseau, JL; Leblond, V; Lévy, V; Maloisel, F; Porcher, R; Remenieras, L	1
Cazin, B; Deconinck, E; Desablens, B; Fermand, JP; Gardembas, M; Guibon, O; Guilhot, F; Harousseau, JL; Leblond, V; Lévy, V; Maloisel, F; Marit, G; Philippe, G; Porcher, R; Remenieras, L; Stamatoullas, A	1
Battista, C; Broccia, G; Capalbo, S; Castoldi, G; Cuneo, A; Leoni, P; Liso, V; Molica, S; Montillo, M; Pogliani, E; Specchia, G	1
Egerer, G; Ho, AD; Sauerland, K	1
Barrett, AJ; Carter, C; Childs, R; de Witte, M; Kang, EM; Leitman, SF; Little, R; Malech, H; Morgan, RA; Phang, S; Tisdale, JF	1
Benyunes, M; Bernstein, SH; Bernstein, ZP; Brown, K; Czuczman, MS; Fallon, A; Grillo-López, AJ; Klippenstein, D; Loud, P; McCarthy, P; Miller, K; Mohr, A; Rock, MK; Skipper, M; Stewart, C; Wentling, D	1
Fezoui, H; Genet, P; Lionnet, F; Louvel, D; Pulik, M; Touahri, T	1
Cerretti, R; De Propriis, MS; Foa, R; Gentile, M; Giannarelli, D; Guarini, A; Mancini, F; Mauro, FR	1
Czuczman, MS	1
Basmaji, N; Garg, MS; Garg, S	1
Bergmann, M; Busch, R; Emmerich, B; Franke, A; Hallek, M; Hiddemann, W; Hopfinger, G; Pasold, R; Schlag, R; Schmitt, B; Wendtner, CM	1
Arcache, J; Arnaud, P; Berger, F; Callet-Bauchu, E; Coiffier, B; Dumontet, C; Felman, P; Hequet, O; Salles, G; Thieblemont, C	1
Ayala, A; Cabanillas, F; Hagemeister, FB; Hess, M; Lee, MS; McLaughlin, P; Preti, A; Rodriguez, MA; Romaguera, J; Sarris, A; Smith, TL; Tsimberidou, AM; Yang, Y; Younes, A	1
Grenier, JF; Guévin, R; Klasa, RJ; Laplante, S; Maksymiuk, A; Meyer, RM; Rubinger, M; Samosh, M; Sawka, CA; Shustik, C; Smith, A	1
Alinari, L; Baccarani, M; Stefoni, V; Tani, M; Zinzani, PL	1
Abebe, L; Adiga, GU; Wiernik, PH	1
Paschal, BR	1
Alliot, C	1
Carta, F; Dore, F; Dore, S; Pinna, A; Salis, A	1
Boumpas, DT; Danning, CL; Davis, JC; Fleisher, TA; Illei, GG; Kuroiwa, T; Schlimgen, R; Takada, K; Tassiulas, IO; Yarboro, CH	1
Stiefelhagen, P	1
Hirayama, Y; Kawano, Y; Kogawa, K; Kuribayashi, K; Matsunaga, T; Murase, K; Niitsu, Y; Okamoto, T; Sato, T; Takayama, T; Watanabe, H	1
Baccarani, M; Fanin, R; Gentile, M; Mandelli, F; Marin, L; Mauro, FR; Stefoni, V; Tura, S; Vegna, ML; Zaja, F; Zinzani, P	1
Abe, Y; Choi, I; Inaba, S; Matsushima, T; Muta, K; Nagasawa, E; Nawata, H; Nishimura, J; Ohtsuka, R; Tachikawa, Y	1
Käser, L; Kolyvanos Naumann, U; Vetter, W	1
Alinari, L; Baccarani, M; Gabriele, A; Marchi, E; Musuraca, G; Pileri, S; Stefoni, V; Tani, M; Zinzani, PL	1
Berthou, C; Casassus, P; Colombat, P; Deconinck, E; Delwail, V; Desablens, B; Foussard, C; Ghandour, C; Gressin, R; Lamy, T; Mahé, B; Maisonneuve, H; Pignon, B; Rachieru, P; Rousselet, MC	1
Chevret, S; Leblond, V; Lévy, V; Morel, P; Porcher, R; Wattel, E	1
Boudreaux, CW; Michael, CW; Richardson, PH	1
Hillmen, P; Johnson, SA; Owen, RG; Rule, SA; Seymour, JF; Thomas, DW; Wolf, MM	1
Gale, R; Gray, A; Hancock, B; Hutchinson, J; Lloyd, A	1
Smolej, L	1
Aly, F; Diehl, V; Rehwald, U; Schmitz, S; Steinmetz, T	1
Kotani, T; Nakamura, Y; Ueda, M; Yamaguchi, M	1
de la Fuente Bobillo, MA; Mendo González, M; Peñarrubia Ponce, MJ; Rodríguez Toves, A; Torres Nieto, A; Vara Castrodeza, A	1
Anhalt, GJ; Cummins, DL; Meyerle, JH; Mimouni, D; Owens, N; Tzu, J	1
Celsing, F; Hansson, L; Karlsson, C; Lundin, J	1
Gadre, SA; Ge, Y; Lockhart, LH; Northup, JK; Velagaleti, GV	1
Arceci, RJ; Chen, AR; Colombani, P; Higman, MA; Schwartz, CL; Wharam, M; Williams, KM	1
Attarbaschi, A; Fritsch, G; Gadner, H; Lawitschka, A; Lion, T; Matthes-Martin, S; Minkov, M; Mittheisz, E; Steiner, M; Zoubek, A	1
Alexandrescu, DT; Wiernik, PH	1
Tan, J; Wu, T; Yang, K	1
Angrilli, F; Baldini, L; Bari, A; Ilariucci, F; Lazzaro, A; Luminari, S; Marcheselli, L; Pozzi, S; Sacchi, S; Stelitano, C	1
Antic, D; Gotic, M; Jakovic, L; Jankovic, S; Mihaljevic, B; Perunicic-Jovanovic, M; Sretenovic, A	1
Janikova, A; Koristek, Z; Kral, Z; Mayer, J; Navratil, M; Pavlik, T; Sticha, M; Vasova, I; Vinklarkova, J	1
Eurelings, M; Franssen, H; Lokhorst, HL; Niermeijer, JM; Notermans, NC; van der Pol, WL; Wokke, JH	1
Jeong, KH; Lew, BL; Sim, WY	1
García-Sanz, R; González-López, TJ; Graciani, IF; Hermida, G; San Miguel, JF; Vázquez, L	1
Andreadis, C; Kanetsky, PA; Nasta, SD; Olin, RL; Schuster, SJ; Ten Have, TR	1
Aarden, L; Baars, JW; Beijnen, JH; Huitema, AD; Tran, L	1
Bishop, MR; Bryant, K; Dean, RM; Fowler, DH; Hakim, F; Jamshed, S; Neelapu, SS; Odom, J; Steinberg, SM	1
Giné, E; Gutiérrez-García, G; López-Guillermo, A	1
Ai, WZ; Czerwinski, DD; Hsu, FJ; Hwang, J; Kohrt, HE; Levy, R; Taidi, B; Timmerman, J	1
Chen, CH; Kuo, CY; Ma, MC; Pei, SN; Rau, KM; Su, CY; Wang, MC	1
Bishop, MR; Bryant, K; Dean, RM; Dunleavy, K; Fowler, DH; Fry, TJ; Gress, RE; Hakim, F; Hughes, TE; Odom, J; Pavletic, SZ; Salit, RB; Steinberg, SM; Wilson, WH	1
Elonen, E; Honkanen, T; Jantunen, E; Jyrkkiö, S; Karjalainen-Lindsberg, ML; Kuittinen, O; Lehto, M; Mikkola, M; Poikonen, E; Räsänen, A; Räty, R; Rauhala, A; Rimpiläinen, J; Siitonen, S; Suominen, M; Vapaatalo, M	1
Fathi, AT; Hasserjian, R; Sadrzadeh, H	1
André, M; Bouabdallah, R; Coiffier, B; Di Raimondo, F; Doorduijn, JK; Dreyling, MH; Feugier, P; Forstpointner, R; Geisler, CH; Hallek, M; Hermine, O; Hiddemann, W; Hoster, E; Kanz, L; Klapper, W; Kluin-Nelemans, HC; Kremers, S; Lepeu, G; Lugtenburg, PJ; Macro, M; Pfreundschuh, M; Procházka, V; Ribrag, V; Sanhes, L; Stilgenbauer, S; Szymczyk, M; Thieblemont, C; Tilly, H; Trneny, M; Unterhalt, M; Uppenkamp, M; Vehling-Kaiser, U; Walewski, J; Zijlstra, JM	1
Fabiano, AJ; Fenstermaker, RA; Qiu, J; Rigual, D	1
Albrecht, M; Bökkerink, J; Claviez, A; Dörffel, W; Holte, H; Karlen, J; Lüders, H; Mann, G; Marciniak, H; Niggli, F; Pötter, R; Rühl, U; Schellong, G; Schmiegelow, K; Schwarze, EW; Wickmann, L	1
Angrilli, F; Arcaini, L; Brugiatelli, M; Carella, AM; Dell'olio, M; Di Raimondo, F; Dondi, A; Federico, M; Franco, V; Gaidano, G; Galimberti, S; Luminari, S; Marcheselli, L; Merli, F; Pulsoni, A; Rigacci, L; Sacchi, S; Stelitano, C; Tucci, A; Vitolo, U	1
Bahlo, J; Böttcher, S; Busch, R; Cramer, P; Döhner, H; Dreger, P; Eichhorst, B; Fink, AM; Fischer, K; Goede, V; Hallek, M; Kneba, M; Langerbeins, P; Mayer, J; Pflug, N; Schubert, F; Stilgenbauer, S; Wendtner, CM	1
Cartron, G; Davies, A; Lei, G; Marcus, R; Morschhauser, F; Radford, J; Salles, G; Vitolo, U; Wassner-Fritsch, E; Wenger, M	1
Byrtek, M; Cerhan, JR; Dawson, K; Flowers, CR; Friedberg, JW; Link, BK; Martin, P; Ziemiecki, R	1
Ambrosetti, A; Attolico, I; Barzan, A; Benedetti, F; Bergui, L; Billio, A; Carlo-Stella, C; Chiarenza, A; Devizzi, L; Di Nicola, M; Di Raimondo, F; Gianni, AM; Gueli, A; Guidetti, A; Intermesoli, T; Magni, M; Matteucci, P; Montanari, M; Mulè, A; Olivieri, A; Parvis, G; Patti, C; Rambaldi, A; Scimè, R; Tarella, C; Trentin, L; Valagussa, P; Viero, P; Viviani, S	1
Aoki, S	1
Imamura, Y	1
Hoang, KQ; Momin, F; Reyes, C; Satram-Hoang, S; Skettino, S	1
Dahllöf, G; Heimdahl, A; Legert, KG; Remberger, M; Ringdén, O	1
Abenhardt, W; Dörfel, S; Grugel, R; Hartmann, H; Knauf, W; Marschner, N; Meyer, D; Münz, M	1
Adam, Z; Krejčí, M; Pour, L; Ševčíková, E	1
Ali, S; Olszewski, AJ; Shafqat, H	1
Anheier, N; Bergmann, M; Busch, R; Cramer, P; Döhner, H; Dürig, J; Eichhorst, B; Fink, AM; Fischer, K; Goebeler, ME; Hallek, M; Hurtz, HJ; Langerbeins, P; Stauch, MB; Stilgenbauer, S; Wendtner, CM	1
Hasegawa, K; Hirayama, Y; Ishihara, T; Kanagawa, M; Koyama, J; Suzuki, T; Terui, T	1
Streu, E	1
Alvarez, I; Anastasia, A; Arcari, A; Bari, A; Botto, B; Carella, AM; Chiarenza, A; Dondi, A; Federico, M; Marcheselli, L; Puccini, B; Salvi, F	1
Annechini, G; Capria, S; D'Elia, GM; De Angelis, F; Foà, R; Pulsoni, A; Russo, E; Stefanizzi, C; Tosti, ME	1
Li, H; Li, Z; Liu, H; Liu, W; Lü, R; Qiu, L; Xiong, W; Yi, S; Zou, D	1
Han, HJ; Lu, YW; Xia, RX	1
Angelucci, E; Angrilli, F; Arcaini, L; Bertoldero, G; Cascavilla, N; Chiarenza, A; Dondi, A; Federico, M; Ferrari, A; Ferreri, AJM; Gaidano, G; Kovalchuk, S; Luminari, S; Manni, M; Marcheselli, L; Merli, F; Pulsoni, A; Rusconi, C; Salvi, F; Stelitano, C; Tarantino, V; Tucci, A; Vallisa, D; Vitolo, U	1
Alonso Caballero, C; Barrenetxea Lekue, C; D'Amore, F; Grasso Cicala, S; Herráez Rodríguez, S; Jørgensen, JM; Leal Martínez, I; Leppä, S; Stauffer Larsen, T; Toldbod, H	1
Doorduijn, JK; Dreyling, MH; Feugier, P; Geisler, CH; Hermine, O; Hoster, E; Kaiser, F; Kanz, L; Klapper, W; Kluin-Nelemans, HC; Pott, C; Ribrag, V; Salles, G; Schmidt, C; Stilgenbauer, S; Szymczyk, M; Thieblemont, C; Tilly, H; Trneny, M; Unterhalt, M; Walewski, J; Zijlstra, JM	1
Beckerleg, W; Milman, N; van der Jagt, R	1
Al Tourah, AJ; Bruyere, H; Dueck, G; Galbraith, P; Gerrie, AS; Hardy, E; Hrynchak, M; Huang, SJ; Noble, MC; Ramadan, KM; Sehn, L; Toze, CL; Tsang, P; Tucker, T; Young, S	1
de Castro, DG; Dietrich, S; Dreger, P; Dreyling, M; Grabe, N; Hermine, O; Hoster, E; Hüttl, K; Klapper, W; Kluin-Nelemans, HC; Müller-Tidow, C; Ott, G; Pott, C; Roider, T; Rosenwald, A; Stewart, JP; Wang, X	1
Cao, L; Du, XY; Fan, L; Li, JY; Wang, F; Wang, L; Xu, W; Zhu, HY	1
Burningham, Z; Chien, HC; Halwani, AS; Li, CY; Morreall, D; Passey, DG; Patil, V; Rasmussen, KM; Sauer, BC; Yong, CM	1

Reviews

18 review(s) available for prednisone and fludarabine

Article	Year
A clinical update on chronic lymphocytic leukemia. II. Critical analysis of current chemotherapeutic modalities. Mayo Clinic proceedings, 1992, Volume: 67, Issue:5 Topics: 2-Chloroadenosine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Chlorambucil; Deoxyadenosines; Dose-Response Relationship, Drug; Histocompatibility Testing; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Pentostatin; Prednisone; Prognosis; Survival Rate; Vidarabine	1992
[Multiple myeloma and other plasma cell dyscrasias]. Revista clinica espanola, 1999, Volume: 199 Suppl 1 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Child; Diagnosis, Differential; Heavy Chain Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Melphalan; Multiple Myeloma; Paraproteinemias; Prednisone; Prognosis; Time Factors; Vidarabine; Waldenstrom Macroglobulinemia	1999
Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect. Annals of the New York Academy of Sciences, 2001, Volume: 938 Topics: Adult; Animals; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclosporine; Disease Progression; Dogs; Forecasting; Graft Enhancement, Immunologic; Graft Survival; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Lymphocyte Transfusion; Methotrexate; Middle Aged; Mycophenolic Acid; Neoplasms; Prednisone; Radiation Chimera; T-Lymphocytes, Cytotoxic; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Whole-Body Irradiation	2001
Rituximab in combination with CHOP or fludarabine in low-grade lymphoma. Seminars in oncology, 2002, Volume: 29, Issue:1 Suppl 2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Vidarabine; Vincristine	2002
Immunochemotherapy in indolent non-Hodgkin's lymphoma. Seminars in oncology, 2002, Volume: 29, Issue:2 Suppl 6 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Vidarabine; Vincristine	2002
Multiple pulmonary nodules: an unusual presentation of fludarabine pulmonary toxicity: case report and review of literature. American journal of hematology, 2002, Volume: 70, Issue:3 Topics: Aged; Antineoplastic Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Diseases; Prednisone; Tomography, X-Ray Computed; Vidarabine	2002
Fludarabine combination therapy for the treatment of chronic lymphocytic leukemia. Clinical lymphoma, 2002, Volume: 3, Issue:1 Topics: Adolescent; Adult; Aged; Alemtuzumab; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Chlorambucil; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Forecasting; Granulocyte Colony-Stimulating Factor; Humans; Immunotherapy; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Randomized Controlled Trials as Topic; Remission Induction; Rituximab; Treatment Outcome; Vidarabine; Vincristine	2002
Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients. Clinical lymphoma, 2002, Volume: 3, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Bleomycin; Bone Marrow; Bone Marrow Diseases; Chemotherapy, Adjuvant; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Paraproteins; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Splenectomy; Splenic Neoplasms; Survival Analysis; Treatment Outcome; Vidarabine; Vincristine	2002
Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review. American journal of hematology, 2003, Volume: 72, Issue:4 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bowen's Disease; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Fatal Outcome; Female; Hodgkin Disease; Humans; Immunophenotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Lomustine; Male; Middle Aged; Mitoxantrone; Neoplasms, Multiple Primary; Neoplastic Stem Cells; Prednisone; Prognosis; Reed-Sternberg Cells; Remission Induction; Skin Neoplasms; Splenectomy; Tumor Virus Infections; Vidarabine; Vinblastine; Vincristine	2003
[Waldenstrom macroglobulinemia]. Praxis, 2004, Mar-31, Volume: 93, Issue:14 Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Blood Transfusion; Chlorambucil; Diagnosis, Differential; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Plasmapheresis; Prednisone; Prognosis; Recurrence; Rituximab; Time Factors; Vidarabine; Waldenstrom Macroglobulinemia	2004
Alkylating agents for Waldenstrom's macroglobulinaemia. The Cochrane database of systematic reviews, 2009, Jan-21, Issue:1 Topics: Alkylating Agents; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Prednisone; Randomized Controlled Trials as Topic; Vidarabine; Waldenstrom Macroglobulinemia	2009
Determinants of the optimal first-line therapy for follicular lymphoma: a decision analysis. American journal of hematology, 2010, Volume: 85, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Decision Support Techniques; Disease Progression; Disease-Free Survival; Doxorubicin; Humans; Immunotherapy; Lymphoma, Follicular; Markov Chains; Prednisone; Quality-Adjusted Life Years; Rituximab; Vidarabine; Vincristine	2010
Current immunochemotherapy strategies in follicular lymphoma. Advances in therapy, 2010, Volume: 27, Issue:10 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Doxorubicin; Humans; Immunotherapy; Lymphoma, Follicular; Nitrogen Mustard Compounds; Prednisone; Radioimmunotherapy; Rituximab; Stem Cell Transplantation; Vidarabine; Vincristine	2010
[Chronic lymphocytic leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:2 Topics: Adenine; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Doxorubicin; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Nitrogen Mustard Compounds; Piperidines; Practice Guidelines as Topic; Prednisone; Pyrazoles; Pyrimidines; Rituximab; Vidarabine; Vincristine	2014
[Hemophagocytic lymphohistiocytosis]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:2 Topics: Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Disease Progression; Doxorubicin; Drug Therapy, Combination; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphohistiocytosis, Hemophagocytic; Methotrexate; Multiple Organ Failure; Prednisolone; Prednisone; Rituximab; Severity of Illness Index; Transplantation Conditioning; Vidarabine; Vincristine	2014
[Therapy of Waldenström´s macroglobulinaemia in the year 2014]. Vnitrni lekarstvi, 2014, Volume: 60, Issue:2 Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bendamustine Hydrochloride; Boronic Acids; Bortezomib; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Immunologic Factors; Immunosuppressive Agents; Nitrogen Mustard Compounds; Prednisone; Pyrazines; Rituximab; Vidarabine; Vincristine; Waldenstrom Macroglobulinemia	2014
Richter syndrome: an aggressive transformation. Oncology nursing forum, 2015, Volume: 42, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Clone Cells; Cyclophosphamide; Disease Progression; Doxorubicin; Hospice and Palliative Care Nursing; Humans; Hypercalcemia; L-Lactate Dehydrogenase; Leukemia, Lymphocytic, Chronic, B-Cell; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Male; Neoplastic Stem Cells; Organoplatinum Compounds; Palliative Care; Prednisone; Prognosis; Risk Factors; Rituximab; Salvage Therapy; Syndrome; Vidarabine; Vincristine	2015
Pixantrone beyond monotherapy: a review. Annals of hematology, 2019, Volume: 98, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Isoquinolines; Lymphoma, B-Cell; Mitoxantrone; Prednisone; Rituximab; Salvage Therapy; Vidarabine; Vincristine	2019

Trials

33 trial(s) available for prednisone and fludarabine

Article	Year
Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with prolymphocytic leukemia and the prolymphocytoid variant of chronic lymphocytic leukemia. The American journal of medicine, 1991, Volume: 90, Issue:2 Topics: Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Agents; Chromosome Aberrations; Chromosome Disorders; Female; Humans; Immunoglobulin M; Karyotyping; Leukemia, Prolymphocytic; Male; Middle Aged; Prednisone; Remission Induction; Vidarabine	1991
Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay. Acta haematologica, 1995, Volume: 93, Issue:2-4 Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Chlorambucil; Cyclophosphamide; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Fatal Outcome; Female; Humans; Ifosfamide; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Melphalan; Methylprednisolone; Middle Aged; Neoplastic Stem Cells; Palliative Care; Pilot Projects; Prednisolone; Prednisone; Remission Induction; Staining and Labeling; Survival Analysis; Treatment Outcome; Tumor Cells, Cultured; Vidarabine; Vinca Alkaloids; Vincristine	1995
FMP regimen (fludarabine, mitoxantrone, prednisone) as therapy in recurrent low-grade non-Hodgkin's lymphoma. European journal of haematology, 1995, Volume: 55, Issue:4 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Prednisone; Recurrence; Vidarabine	1995
Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group Seminars in oncology, 1993, Volume: 20, Issue:5 Suppl 7 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Neoplasm Staging; Prednisone; Remission Induction; Survival Rate; Vidarabine; Vincristine	1993
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment. Blood, 1993, Sep-15, Volume: 82, Issue:6 Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; Drug Administration Schedule; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisone; Prognosis; Regression Analysis; Survival Analysis; Time Factors; Treatment Outcome; Vidarabine	1993
When and how to treat elderly patients with chronic lymphocytic leukemia (C.L.L.)? The French Cooperative Group on C.L.L. Hematological oncology, 1993, Volume: 11 Suppl 1 Topics: Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Multivariate Analysis; Neoplasm Staging; Peptichemio; Prednisone; Sex Factors; Vidarabine; Vincristine	1993
Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL. Lancet (London, England), 1996, May-25, Volume: 347, Issue:9013 Topics: Agranulocytosis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Prednisone; Prospective Studies; Remission Induction; Survival Rate; Time Factors; Vidarabine	1996
Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Recurrence; Treatment Outcome; Vidarabine	1997
A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures. The Journal of rheumatology, 1999, Volume: 26, Issue:2 Topics: Adult; Aged; Anti-Inflammatory Agents; Dermatomyositis; Edema; Female; Flow Cytometry; Hematologic Tests; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Pilot Projects; Polymyositis; Prednisone; Treatment Outcome; Vidarabine	1999
Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: a GELA study. Groupe d'Etudes des Lymphomes de l'Adulte. Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:10 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Interferons; Lymphoma, Follicular; Male; Middle Aged; Multivariate Analysis; Prednisone; Prognosis; Survival Analysis; Teniposide; Vidarabine	1999
Unsuccessful treatment with fludarabine in four cases of refractory rheumatoid arthritis. Clinical rheumatology, 2000, Volume: 19, Issue:6 Topics: Arthritis, Rheumatoid; Disease Progression; Female; Humans; Immunosuppressive Agents; Lymphocyte Count; Male; Middle Aged; Prednisone; Treatment Failure; Vidarabine	2000
Evaluating treatment strategies in chronic lymphocytic leukemia: use of quality-adjusted survival analysis. Journal of clinical epidemiology, 2001, Volume: 54, Issue:7 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Prednisone; Quality of Life; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Survival Analysis; Treatment Outcome; Vidarabine; Vincristine	2001
Evaluating treatment strategies in advanced Waldenström macroglobulinemia: use of quality-adjusted survival analysis. Leukemia, 2001, Volume: 15, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Health Status Indicators; Humans; Prednisone; Quality of Life; Retrospective Studies; Survival Rate; Vidarabine; Waldenstrom Macroglobulinemia	2001
Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease. Blood, 2001, Nov-01, Volume: 98, Issue:9 Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance; Female; Humans; Male; Middle Aged; Mouth Mucosa; Prednisone; Recurrence; Salvage Therapy; Stomatitis; Survival Analysis; Therapeutic Equivalency; Treatment Outcome; Vidarabine; Waldenstrom Macroglobulinemia	2001
Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma. Blood, 2002, Dec-15, Volume: 100, Issue:13 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematologic Diseases; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisone; Procarbazine; Prognosis; Remission Induction; Survival Rate; Vidarabine; Vincristine	2002
Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Dec-15, Volume: 20, Issue:24 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Quality of Life; Survival Rate; Treatment Outcome; Vidarabine; Vincristine	2002
Lymphocyte depletion with fludarabine in patients with psoriatic arthritis: clinical and immunological effects. Annals of the rheumatic diseases, 2003, Volume: 62, Issue:11 Topics: Adult; Anti-Inflammatory Agents; Arthritis, Psoriatic; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; DNA-Binding Proteins; E-Selectin; Endothelial Cells; Female; Humans; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Lymphocyte Depletion; Male; Middle Aged; P-Selectin; Phosphorylation; Prednisone; STAT1 Transcription Factor; Synovial Membrane; Trans-Activators; Vidarabine	2003
Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study. Haematologica, 2003, Volume: 88, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Disease Progression; Drug Administration Schedule; Female; Humans; Interferon-alpha; Leukemia, Lymphocytic, Chronic, B-Cell; Life Tables; Male; Middle Aged; Neoplasms, Second Primary; Prednisone; Prognosis; Remission Induction; Survival Analysis; Treatment Outcome; Vidarabine	2003
Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:3 Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Risk Factors; Vidarabine; Vindesine	2005
Advanced Waldenström's macroglobulinemia: usefulness of Morel's scoring system in establishing prognosis. Haematologica, 2005, Volume: 90, Issue:2 Topics: Aged; Antineoplastic Agents; Cohort Studies; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Male; Middle Aged; Multivariate Analysis; Prednisone; Prognosis; Time Factors; Vidarabine; Waldenstrom Macroglobulinemia	2005
Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphoma. Cancer, 2009, May-01, Volume: 115, Issue:9 Topics: Adult; Aged; Anthracyclines; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Genes, bcl-2; Humans; Lymphoma, Follicular; Male; Middle Aged; Mitoxantrone; Prednisone; Remission Induction; Rituximab; Survival Analysis; Vidarabine; Vincristine	2009
Rituximab for polyneuropathy with IgM monoclonal gammopathy. Journal of neurology, neurosurgery, and psychiatry, 2009, Volume: 80, Issue:9 Topics: Age of Onset; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; B-Lymphocytes; Bone Marrow Cells; Cyclophosphamide; Disability Evaluation; Female; Humans; Immunoglobulin M; Immunologic Factors; Immunosuppressive Agents; Lymphocyte Count; Male; Middle Aged; Muscle Strength; Neural Conduction; Paraproteinemias; Prednisone; Prospective Studies; Rituximab; Sensation; Treatment Outcome; Vidarabine	2009
Prolonged disease-free survival and overall survival with CVP alternating with fludarabine in advanced follicular lymphoma. American journal of hematology, 2011, Volume: 86, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Humans; Immunotherapy, Active; Lymphoma, Follicular; Middle Aged; Prednisone; Treatment Outcome; Vidarabine; Vincristine; Young Adult	2011
Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma: a prospective study Leukemia & lymphoma, 2012, Volume: 53, Issue:10 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Induction Chemotherapy; Lymphoma, Mantle-Cell; Maintenance Chemotherapy; Male; Prednisone; Rituximab; Treatment Outcome; Vidarabine; Vincristine	2012
Treatment of older patients with mantle-cell lymphoma. The New England journal of medicine, 2012, Aug-09, Volume: 367, Issue:6 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Induction Chemotherapy; Intention to Treat Analysis; Lymphoma, Mantle-Cell; Maintenance Chemotherapy; Male; Middle Aged; Prednisone; Prospective Studies; Remission Induction; Rituximab; Survival Rate; Vidarabine; Vincristine	2012
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Apr-20, Volume: 31, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Follicular; Male; Middle Aged; Mitoxantrone; Neoplasm Grading; Neoplasm Staging; Prednisone; Prognosis; Prospective Studies; Survival Rate; Vidarabine; Vincristine	2013
Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000). Blood, 2013, Aug-15, Volume: 122, Issue:7 Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Prognosis; Vidarabine; Vincristine	2013
Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis. Bone marrow transplantation, 2014, Volume: 49, Issue:4 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Melphalan; Middle Aged; Prednisone; Prospective Studies; Rituximab; Transplantation, Autologous; Vidarabine; Vincristine	2014
Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation. American journal of hematology, 2014, Volume: 89, Issue:12 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Hemoglobins; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Recurrence; Rituximab; Survival Analysis; Treatment Failure; Vidarabine; Vincristine	2014
Prognostic roles of absolute monocyte and absolute lymphocyte counts in patients with advanced-stage follicular lymphoma in the rituximab era: an analysis from the FOLL05 trial of the Fondazione Italiana Linfomi. British journal of haematology, 2015, Volume: 169, Issue:4 Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphocyte Count; Lymphocytes; Lymphoma, Follicular; Male; Middle Aged; Mitoxantrone; Monocytes; Prednisone; Prospective Studies; Rituximab; Survival Rate; Vidarabine; Vincristine	2015
[Clinical Efficacy and Safety of Rituximab Combined with Fludarabine and Cyclophosphamide for Treatment of Chronic Lymphocytic Leukemia]. Zhongguo shi yan xue ye xue za zhi, 2016, Volume: 24, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Prednisone; Rituximab; Treatment Outcome; Vidarabine; Vincristine	2016
Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020, 01-20, Volume: 38, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Lymphoma, Mantle-Cell; Maintenance Chemotherapy; Male; Middle Aged; Prednisone; Progression-Free Survival; Rituximab; Time; Vidarabine; Vincristine	2020
The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial. International journal of cancer, 2021, 01-01, Volume: 148, Issue:1 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Line, Tumor; Cyclophosphamide; Cytarabine; Disease-Free Survival; DNA Mutational Analysis; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Male; Middle Aged; Mutation; Oxaliplatin; Prednisone; Primary Cell Culture; Rituximab; SAM Domain and HD Domain-Containing Protein 1; Tissue Array Analysis; Vidarabine; Vincristine	2021

Other Studies

78 other study(ies) available for prednisone and fludarabine

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Interaction of human organic anion transporter polypeptides 1B1 and 1B3 with antineoplastic compounds. European journal of medicinal chemistry, 2015, Mar-06, Volume: 92 Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Humans; Liver-Specific Organic Anion Transporter 1; Molecular Structure; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Peptides; Solute Carrier Organic Anion Transporter Family Member 1B3	2015
Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone. Annals of internal medicine, 1992, Sep-15, Volume: 117, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Listeriosis; Male; Middle Aged; Prednisone; Retrospective Studies; Vidarabine	1992
Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis. Blood, 1992, Jul-01, Volume: 80, Issue:1 Topics: Adult; Aged; Antigens, CD; Antigens, CD20; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; CD5 Antigens; Female; Flow Cytometry; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Gene Rearrangement, B-Lymphocyte, Light Chain; Genes, Immunoglobulin; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Subsets; Male; Middle Aged; Prednisone; Survival Analysis; Vidarabine	1992
Factor VIII inhibitor prior to and during secondary acute nonlymphocytic leukemia in a patient with cured Hodgkin's disease. Leukemia & lymphoma, 1995, Volume: 16, Issue:5-6 Topics: Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Blood Transfusion; Combined Modality Therapy; Cytarabine; Factor VIII; Female; Granulocyte Colony-Stimulating Factor; Hemophilia A; Hemorrhage; Hodgkin Disease; Humans; Immunologic Factors; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lymphatic Irradiation; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Plasmapheresis; Prednisone; Procarbazine; Prothrombin; Remission Induction; Thrombocytopenia; Vidarabine; Vincristine	1995
Treatment of refractory T-cell chronic lymphocytic leukemia with purine nucleoside analogues. Leukemia & lymphoma, 1994, Volume: 14, Issue:1-2 Topics: 2-Chloroadenosine; Anemia; Antineoplastic Combined Chemotherapy Protocols; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclophosphamide; Deoxyadenosines; Fatal Outcome; Female; Humans; Immunophenotyping; Leukemia, Prolymphocytic; Leukemia, Prolymphocytic, T-Cell; Male; Methotrexate; Middle Aged; Neoplastic Stem Cells; Prednisone; Salvage Therapy; Vidarabine; Vincristine; Zidovudine	1994
Late listeriosis after fludarabine plus prednisone treatment. British journal of haematology, 1994, Volume: 87, Issue:2 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Fatal Outcome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Listeriosis; Male; Opportunistic Infections; Prednisone; Time Factors; Vidarabine	1994
Pentostatin increases the acute toxicity of high dose cyclophosphamide. Bone marrow transplantation, 1993, Volume: 12, Issue:3 Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Synergism; Etoposide; Fatal Outcome; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Pentostatin; Prednisone; Rats; Rats, Inbred Lew; Salvage Therapy; Shock, Cardiogenic; Ventricular Fibrillation; Vidarabine; Vincristine	1993
Listerial brain abscess in a patient with chronic lymphocytic leukemia treated with fludarabine. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 17, Issue:4 Topics: Aged; Antineoplastic Agents; Brain Abscess; Cefotaxime; Drug Therapy, Combination; Gentamicins; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Listeriosis; Male; Prednisone; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination; Vidarabine	1993
Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with fludarabine. Blood, 1996, Sep-15, Volume: 88, Issue:6 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Immunoblastic Lymphadenopathy; Male; Middle Aged; Prednisone; Vidarabine; Vincristine	1996
Chronic lymphocytic leukemia in the elderly population. Clinics in geriatric medicine, 1997, Volume: 13, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Chlorambucil; Female; Humans; Incidence; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Prednisone; United States; Vidarabine	1997
Steroid-responsive interstitial pneumonitis after fludarabine therapy. Chest, 1997, Volume: 111, Issue:5 Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Cough; Fatal Outcome; Glucocorticoids; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Diseases, Interstitial; Male; Neoplasm Recurrence, Local; Prednisolone; Prednisone; Respiratory Distress Syndrome; Respiratory Insufficiency; Vidarabine	1997
Listeriosis after fludarabine treatment for chronic lymphocytic leukemia. Hematology and cell therapy, 1997, Volume: 39, Issue:2 Topics: Aged; Antineoplastic Agents; Chlorambucil; Cyclophosphamide; Doxorubicin; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Listeriosis; Prednisone; Sulfamethoxazole; Trimethoprim; Vidarabine; Vincristine	1997
[Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukemia]. Sangre, 1997, Volume: 42, Issue:3 Topics: Anemia, Hemolytic, Autoimmune; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Chlorambucil; Cyclophosphamide; Cyclosporine; Doxorubicin; Humans; Hydrocortisone; Interferon-alpha; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Red-Cell Aplasia, Pure; Vidarabine; Vincristine	1997
Fatal CMV pneumonia associated with steroid therapy after autologous transplantation in patients previously treated with fludarabine. Bone marrow transplantation, 1998, Volume: 21, Issue:6 Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytomegalovirus Infections; Doxorubicin; Drug Synergism; Female; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Pneumonia, Viral; Prednisolone; Prednisone; Transplantation Conditioning; Transplantation, Autologous; Vidarabine; Vincristine; Viral Load	1998
Prolonged disease-free survival in relapsed/refractory low-grade lymphoma treated with fludarabine: a report of four cases. British journal of haematology, 1998, Volume: 102, Issue:2 Topics: Adult; Anthracyclines; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vidarabine; Vincristine	1998
Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Annals of internal medicine, 1998, Oct-01, Volume: 129, Issue:7 Topics: Analysis of Variance; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Logistic Models; Neoplasm Staging; Opportunistic Infections; Prednisone; Retrospective Studies; Risk Factors; Vidarabine	1998
Fludarabine-related hemolytic anemia in chronic lymphocytic leukemia and lymphoproliferative disorders. American journal of hematology, 1998, Volume: 59, Issue:4 Topics: Aged; Anemia, Hemolytic; Antimetabolites, Antineoplastic; Humans; Immunosuppressive Agents; Incidence; Infection Control; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Retrospective Studies; Vidarabine	1998
Fatal myelofibrosis following fludarabine administration in a patient with indolent lymphoma. Haematologica, 1998, Volume: 83, Issue:11 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fatal Outcome; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pancytopenia; Prednisone; Primary Myelofibrosis; Vidarabine; Vincristine	1998
Refractory pure red cell aplasia associated with B-CLL: successful treatment with a combination of fludarabine, cyclosporin A and erythropoietin. Leukemia, 1999, Volume: 13, Issue:1 Topics: Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; CD4-CD8 Ratio; Cyclosporine; Erythropoietin; Hemoglobins; Humans; Immunoglobulins, Intravenous; Immunophenotyping; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Prednisone; Red-Cell Aplasia, Pure; Vidarabine	1999
Evan's syndrome precipitated by fludarabine therapy in a case of CLL. American journal of hematology, 1999, Volume: 61, Issue:3 Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Female; Humans; Immune Tolerance; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Prednisone; Thrombocytopenia; Vidarabine	1999
Cost-minimization analysis of CHOP, fludarabine and rituximab for the treatment of relapsed indolent B-cell non-Hodgkin's lymphoma in the U.K. British journal of haematology, 1999, Volume: 106, Issue:1 Topics: Ambulatory Care; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Costs and Cost Analysis; Cyclophosphamide; Doxorubicin; Humans; Length of Stay; Lymphoma, B-Cell; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Rituximab; Vidarabine; Vincristine	1999
A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy. Clinical nephrology, 1999, Volume: 52, Issue:2 Topics: Adult; Alkylating Agents; Anti-Inflammatory Agents; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Humans; Immunoglobulin G; Immunologic Memory; Immunosuppressive Agents; Lupus Nephritis; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Pilot Projects; Prednisone; Proteinuria; Renal Plasma Flow, Effective; Sinusitis; Vidarabine	1999
[Chronic lymphatic leukemia and Hodgkin's disease]. Sangre, 1999, Volume: 44, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Neoplasms, Second Primary; Prednisone; Remission Induction; Vidarabine; Vinblastine	1999
UCN-01 induces cytotoxicity toward human CLL cells through a p53-independent mechanism. Experimental hematology, 2001, Volume: 29, Issue:6 Topics: Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Cell Survival; Cells, Cultured; Chlorambucil; Drug Resistance, Multiple; Genes, bcl-2; Humans; Interleukin-4; Kinetics; Leukemia, Lymphocytic, Chronic, B-Cell; Mice; Mice, Inbred C57BL; Mice, Knockout; Prednisone; Proto-Oncogene Proteins c-bcl-2; Spleen; Staurosporine; Thymus Gland; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vidarabine	2001
Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy. Haematologica, 2001, Volume: 86, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Drug Resistance; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Prednisone; Retrospective Studies; Treatment Outcome; Vidarabine; Vincristine	2001
Remarkable response to rituximab in a 72-year-old patient with refractory non-Hodgkin's lymphoma and marrow aplasia. Leukemia & lymphoma, 2001, Volume: 42, Issue:3 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Cyclophosphamide; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Pancytopenia; Prednisone; Red-Cell Aplasia, Pure; Rituximab; Treatment Outcome; Vidarabine; Vincristine	2001
Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome. Blood, 2002, Jan-15, Volume: 99, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Cyclosporine; Feasibility Studies; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Infection Control; Leukemia, Myeloid; Prednisone; Premedication; Recurrence; Remission Induction; Transplantation Conditioning; Treatment Outcome; Vidarabine; Viral Load	2002
Toxoplasmic encephalitis in a non-HIV patient with follicular lymphoma. International journal of hematology, 2002, Volume: 75, Issue:1 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Immunocompromised Host; Interferon-alpha; Lymphoma, Follicular; Opportunistic Infections; Prednisone; Salvage Therapy; Teniposide; Toxoplasmosis, Cerebral; Vidarabine	2002
Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone. Haematologica, 2002, Volume: 87, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Male; Middle Aged; Multivariate Analysis; Prednisone; Prognosis; Staining and Labeling; Survival Analysis; Vidarabine	2002
Waldenstrom's macroglobulinemia: is there a place and time for a cease-fire? Leukemia research, 2003, Volume: 27, Issue:5 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case Management; Chlorambucil; Cladribine; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Immunoglobulin M; Male; Middle Aged; Mitoxantrone; Plasmapheresis; Prednisone; Rituximab; Severity of Illness Index; Thalidomide; Vidarabine; Vinblastine; Vincristine; Vinorelbine; Waldenstrom Macroglobulinemia	2003
Remission of follicular non-Hodgkin's lymphoma with denileukin diftitox (ONTAK) after progression during rituximab, CHOP and fludarabine therapy. Leukemia & lymphoma, 2003, Volume: 44, Issue:4 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diphtheria Toxin; Disease Progression; Doxorubicin; Humans; Interleukin-2; Lymphoma, Non-Hodgkin; Male; Peripheral Blood Stem Cell Transplantation; Prednisone; Recombinant Fusion Proteins; Remission Induction; Rituximab; Time Factors; Vidarabine; Vincristine	2003
Fludarabine versus cyclophosphamide, vincristine, and prednisone in recurrent low-grade lymphomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Jul-01, Volume: 21, Issue:13 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Lymphoma, Non-Hodgkin; Prednisone; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Reproducibility of Results; Social Behavior; Survival; Vidarabine; Vincristine	2003
Bilateral optic disc swelling as the presenting sign of Waldenström's macroglobulinaemia. Acta ophthalmologica Scandinavica, 2003, Volume: 81, Issue:4 Topics: Adult; Cyclophosphamide; Drug Therapy, Combination; Erythrocyte Transfusion; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Optic Disk; Papilledema; Prednisone; Vidarabine; Waldenstrom Macroglobulinemia	2003
[Pressure pain in the left epigastrium: blood picture provides diagnosis. Chronic lymphatic leukemia]. MMW Fortschritte der Medizin, 2003, Sep-25, Volume: 145, Issue:39 Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Chlorambucil; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytosis; Lymphocyte Count; Male; Middle Aged; Prednisone; Splenomegaly; Time Factors; Ultrasonography; Vidarabine	2003
Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement. International journal of clinical oncology, 2003, Volume: 8, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Drug Resistance, Neoplasm; Humans; Intestinal Polyposis; Leukemia, Prolymphocytic; Leukemia, T-Cell; Male; Prednisone; Transplantation, Homologous; Treatment Outcome; Vidarabine; Vincristine	2003
45th annual meeting of the American Society of Hematology. December 6-9, 2003, San Diego, California. Clinical lymphoma, 2003, Volume: 4, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Diphtheria Toxin; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Female; Hodgkin Disease; Humans; Interleukin-2; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Male; Middle Aged; Prednisone; Recombinant Fusion Proteins; Retrospective Studies; Rituximab; Time Factors; Treatment Outcome; Vidarabine; Vincristine	2003
Successful treatment with nonmyeloablative allogeneic hematopoietic stem cell transplantation in a patient with acute myeloid leukemia complicated with pulmonary infection. International journal of hematology, 2004, Volume: 79, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Combined Modality Therapy; Cyclosporine; Cytarabine; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myeloid; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pneumonia; Prednisone; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vidarabine	2004
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer, 2004, May-15, Volume: 100, Issue:10 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; DNA (Cytosine-5-)-Methyltransferases; Female; Gastrointestinal Neoplasms; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Survival Rate; Treatment Outcome; Vidarabine; Vincristine	2004
Pulmonary lymphoma of the mucosa-associated lymphoid tissue type: Report of a case with cytological, histological, immunophenotypical correlation, and review of the literature. Annals of diagnostic pathology, 2005, Volume: 9, Issue:3 Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chlorambucil; Cyclophosphamide; Doxorubicin; Female; Humans; Immunophenotyping; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Treatment Outcome; Vidarabine; Vincristine	2005
Superior quality and duration of responses among patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide with or without rituximab compared with prior responses to CHOP. Leukemia & lymphoma, 2005, Volume: 46, Issue:4 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Humans; Lymphoma, Mantle-Cell; Middle Aged; Prednisone; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Treatment Outcome; Vidarabine; Vincristine	2005
Costs of chemotherapy for indolent follicular non-Hodgkin's lymphoma in the UK: an observational study. Acta haematologica, 2006, Volume: 115, Issue:1-2 Topics: Antineoplastic Combined Chemotherapy Protocols; Costs and Cost Analysis; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Health Services; Humans; Lymphoma, Follicular; Male; Middle Aged; Prednisone; Retrospective Studies; United Kingdom; Vidarabine; Vincristine	2006
Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice? Leukemia research, 2007, Volume: 31, Issue:2 Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Hepatitis B; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Prednisone; Rituximab; Treatment Outcome; Vidarabine	2007
Sensitivity analysis of cost factors for various therapy options in the treatment of follicular lymphoma. Onkologie, 2006, Volume: 29, Issue:6 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Computer Simulation; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; European Union; Fees and Charges; Germany; Health Care Costs; Humans; Lymphoma, Follicular; Male; Models, Economic; Prednisone; Reproducibility of Results; Rituximab; Sensitivity and Specificity; Vidarabine; Vincristine	2006
Successful treatment of refractory peripheral T-cell lymphoma with a combination of fludarabine and cyclophosphamide. International journal of hematology, 2006, Volume: 83, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Methylprednisolone; Neoplasms, Second Primary; Prednisone; Recurrence; Remission Induction; Time Factors; Vidarabine; Vincristine	2006
Diagnosis of a primary testicular lymphoma by echography and magnetic resonance imaging. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2006, Volume: 8, Issue:6 Topics: Aged; alpha-Fetoproteins; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Methotrexate; Neoplasm Proteins; Orchiectomy; Prednisone; Prognosis; Rituximab; Testicular Neoplasms; Ultrasonography; Vidarabine; Vincristine	2006
Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies. Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:1 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; B-Lymphocytes; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Esophageal Diseases; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunity, Cellular; Interleukin-2; Leukemia, Lymphocytic, Chronic, B-Cell; Lichenoid Eruptions; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mucositis; Paraneoplastic Syndromes; Pemphigus; Prednisone; Recurrence; Rituximab; T-Lymphocytes; Vidarabine; Vincristine	2007
Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody). Leukemia, 2007, Volume: 21, Issue:3 Topics: Aged; Alemtuzumab; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antigens, CD; Antigens, Neoplasm; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; CD52 Antigen; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Drug Resistance; Glycoproteins; Hemoglobins; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Prednisone; Splenectomy; Treatment Outcome; Vidarabine; Vincristine	2007
Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition? European journal of haematology, 2007, Volume: 78, Issue:2 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Burkitt Lymphoma; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Chromosomes, Human, Pair 8; Chromosomes, Human, X; Clone Cells; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Female; Genes, myc; Humans; Karyotyping; Lymph Nodes; Lymphoma, AIDS-Related; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Mutagenesis, Insertional; Pleural Effusion, Malignant; Prednisone; Rituximab; Translocation, Genetic; Trisomy; Vidarabine; Vincristine	2007
Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma. Pediatric blood & cancer, 2008, Volume: 50, Issue:3 Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biliary Atresia; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunocompromised Host; Immunosuppressive Agents; Liver Transplantation; Lymphoma, T-Cell, Peripheral; Lymphoproliferative Disorders; Melphalan; Mesna; Postoperative Complications; Prednisone; Radiotherapy, Adjuvant; Transplantation, Autologous; Vidarabine; Vincristine	2008
Importance of allogeneic T-cells for disease control after stem cell transplantation for high-risk Langerhans cell histiocytosis. Haematologica, 2007, Volume: 92, Issue:1 Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Bone Marrow Transplantation; Combined Modality Therapy; Drug Therapy, Combination; Etoposide; Female; Graft Survival; Histiocytosis, Langerhans-Cell; Humans; Infant; Lymphocyte Transfusion; Lymphohistiocytosis, Hemophagocytic; Melphalan; Prednisone; Remission Induction; T-Lymphocyte Subsets; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Vinblastine	2007
Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia. Medical oncology (Northwood, London, England), 2008, Volume: 25, Issue:3 Topics: Agammaglobulinemia; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Biomarkers; Chlorambucil; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Rituximab; Serum Globulins; Vidarabine	2008
T-cell large granular lymphocytic (T-LGL) leukemia: a single institution experience. Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Leukemia, Large Granular Lymphocytic; Male; Middle Aged; Prednisone; Vidarabine; Vincristine	2010
Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients. Experimental hematology, 2009, Volume: 37, Issue:11 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Diseases; Colony-Forming Units Assay; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Follow-Up Studies; Hematopoietic Stem Cells; Humans; Interferon-alpha; Lymphoma, Follicular; Male; Middle Aged; Mitoxantrone; Peripheral Blood Stem Cell Transplantation; Prednisone; Procarbazine; Retrospective Studies; Rituximab; Vidarabine; Vincristine	2009
Generalized leukaemia cutis from a small cell variant of T-cell prolymphocytic leukaemia presenting with exfoliative dermatitis. Acta dermato-venereologica, 2009, Volume: 89, Issue:5 Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Examination; Dermatitis, Exfoliative; Diagnostic Errors; Erythema; Fatal Outcome; Humans; Immunophenotyping; Leukemia, Prolymphocytic, T-Cell; Leukemic Infiltration; Male; Prednisone; Skin; T-Lymphocytes; Treatment Failure; Vidarabine	2009
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma. European journal of haematology, 2010, Volume: 84, Issue:3 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Hodgkin Disease; Humans; Male; Mechlorethamine; Melphalan; Organoplatinum Compounds; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prednisone; Procarbazine; Remission Induction; Rituximab; Salvage Therapy; Thalidomide; Topotecan; Transplantation, Autologous; Vidarabine; Vinblastine; Vincristine	2010
Pharmacokinetics of rituximab in patients with CD20 positive B-cell malignancies. Human antibodies, 2010, Volume: 19, Issue:1 Topics: Adult; Aged; Antibodies; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Carmustine; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Rituximab; Treatment Outcome; Vidarabine; Vincristine; Vindesine	2010
EPOCH-F: a novel salvage regimen for multiple myeloma before reduced-intensity allogeneic hematopoietic SCT. Bone marrow transplantation, 2011, Volume: 46, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Multiple Myeloma; Prednisone; Salvage Therapy; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Vincristine	2011
Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy. Annals of hematology, 2012, Volume: 91, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Humans; Lymphoma, B-Cell; Male; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Serologic Tests; Titrimetry; Vidarabine; Vincristine; Virus Activation	2012
Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Mar-10, Volume: 30, Issue:8 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Flow Cytometry; Hematopoietic Stem Cell Transplantation; Humans; Interleukin-15; Interleukin-7; Lymphocyte Depletion; Lymphoma; Male; Middle Aged; Prednisone; Rituximab; Salvage Therapy; Treatment Outcome; Vidarabine; Vincristine	2012
Pure erythroid leukemia evolving from a therapy-related myelodysplastic syndrome secondary to treatment for chronic lymphocytic leukemia. American journal of hematology, 2013, Volume: 88, Issue:3 Topics: Abnormal Karyotype; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamide; Fatal Outcome; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Myelodysplastic Syndromes; Prednisone; Vidarabine; Vincristine	2013
Tumoral Bing-Neel Syndrome presenting as a cerebellar mass. Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:6 Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Brain Edema; Cerebellar Neoplasms; Cyclophosphamide; Dexamethasone; Doxorubicin; Fatal Outcome; Humans; Lenalidomide; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Nervous System Diseases; Neurosurgical Procedures; Prednisone; Rituximab; Thalidomide; Treatment Outcome; Vidarabine; Vincristine; Waldenstrom Macroglobulinemia	2013
Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Apr-20, Volume: 31, Issue:12 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; International Agencies; Male; Neoplasm Grading; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Remission Induction; Survival Rate; Vidarabine; Vincristine	2013
Second-line therapies of patients initially treated with fludarabine and cyclophosphamide or fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia within the CLL8 protocol of the German CLL Study Group. Leukemia & lymphoma, 2013, Volume: 54, Issue:8 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Prednisone; Rituximab; Treatment Outcome; Vidarabine; Vincristine	2013
Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare Study. Cancer, 2013, Dec-01, Volume: 119, Issue:23 Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Follicular; Male; Middle Aged; Observational Studies as Topic; Prednisone; Prospective Studies; Rituximab; Treatment Outcome; United States; Vidarabine; Vincristine	2013
Treatment practice in the elderly patient with chronic lymphocytic leukemia-analysis of the combined SEER and Medicare database. Annals of hematology, 2014, Volume: 93, Issue:8 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Comorbidity; Cyclophosphamide; Databases, Factual; Disease Management; Doxorubicin; Ethnicity; Female; Humans; Immunotherapy; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Medicare; Practice Patterns, Physicians'; Prednisone; Rituximab; SEER Program; Socioeconomic Factors; Treatment Outcome; United States; Vidarabine; Vincristine	2014
Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014, Volume: 22, Issue:8 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Cyclophosphamide; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Multivariate Analysis; Oral Hygiene; Prednisone; Sirolimus; Stomatitis; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation; Young Adult	2014
Routine treatment of patients with chronic lymphocytic leukaemia by office-based haematologists in Germany-data from the Prospective Tumour Registry Lymphatic Neoplasms. Hematological oncology, 2015, Volume: 33, Issue:1 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Chlorambucil; Cyclophosphamide; Female; Germany; Hematology; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Nitrogen Mustard Compounds; Office Visits; Prednisone; Prospective Studies; Registries; Rituximab; Vidarabine	2015
Disparate survival outcomes after front-line chemoimmunotherapy in older patients with follicular, nodal marginal zone and small lymphocytic lymphoma. Leukemia & lymphoma, 2015, Volume: 56, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Febrile Neutropenia; Female; Humans; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Male; Outcome Assessment, Health Care; Prednisone; Rituximab; SEER Program; Survival Analysis; United States; Vidarabine; Vincristine	2015
B-cell lymphoma developing de novo hepatitis B after salvage therapies including rituximab through seroconversion of surface antibody. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:11 Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lymphoma, B-Cell; Prednisone; Recurrence; Remission Induction; Risk; Rituximab; Salvage Therapy; Vidarabine; Vincristine; Virus Activation	2014
Risk of secondary hypogammaglobulinaemia after Rituximab and Fludarabine in indolent non-Hodgkin lymphomas: A retrospective cohort study. Leukemia research, 2015, Volume: 39, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Disease Susceptibility; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; IgG Deficiency; Immunocompromised Host; Immunotherapy; Incidence; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pneumonia; Prednisone; Proportional Hazards Models; Retrospective Studies; Rituximab; Transplantation, Autologous; Vidarabine; Vincristine; Young Adult	2015
[Curative effect analysis of rituximab combined with intensive chemotherapy for follicular lymphoma patients with bone marrow involvement]. Zhonghua yi xue za zhi, 2015, Nov-24, Volume: 95, Issue:44 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Humans; Lymphoma, Follicular; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Treatment Outcome; Vidarabine; Vincristine; Young Adult	2015
Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 03-01, Volume: 36, Issue:7 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Lymphoma, Follicular; Middle Aged; Mitoxantrone; Neoplasm Staging; Prednisone; Rituximab; Vidarabine; Vincristine	2018
Systemic Large-Vessel Vasculitis and Retroperitoneal Fibrosis in the Setting of T-Cell Chronic Lymphocytic Leukemia: A Case Report. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2020, Volume: 26, Issue:2 Topics: Aged; Antineoplastic Agents; Aorta, Thoracic; Chest Pain; Computed Tomography Angiography; Coronary Vessels; Cyclophosphamide; Humans; Leukemia, Prolymphocytic, T-Cell; Lymphadenopathy; Male; Prednisone; Retroperitoneal Fibrosis; Systemic Vasculitis; Treatment Outcome; Vidarabine	2020
Comparison of real-world treatment patterns in chronic lymphocytic leukemia management before and after availability of ibrutinib in the province of British Columbia, Canada. Leukemia research, 2020, Volume: 91 Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; British Columbia; Chromosome Deletion; Chromosomes, Human, Pair 17; Cyclophosphamide; Disease Management; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm, Residual; Piperidines; Prednisone; Prognosis; Pyrazoles; Pyrimidines; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Smith-Magenis Syndrome; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Vidarabine; Vincristine	2020
Chronic lymphocytic leukemia-associated paraneoplastic pemphigus: potential cause and therapeutic strategies. Scientific reports, 2020, 10-01, Volume: 10, Issue:1 Topics: Adult; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Paraneoplastic Syndromes; Pemphigus; Prednisone; Prognosis; Retrospective Studies; Rituximab; Vidarabine	2020
Real-world treatment patterns and outcomes in a national study of veterans with Waldenström macroglobulinemia, 2006-2019. American journal of hematology, 2021, 06-01, Volume: 96, Issue:6 Topics: Adenine; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bortezomib; Chlorambucil; Cyclophosphamide; Dexamethasone; Doxorubicin; Humans; Kaplan-Meier Estimate; Piperidines; Prednisone; Progression-Free Survival; Proportional Hazards Models; Retrospective Studies; Rituximab; Treatment Outcome; Veterans; Vidarabine; Vincristine; Waldenstrom Macroglobulinemia	2021